In other words, according to in vitro studies and clinical observation, deficiency of SEMA6B (described earlier) and SEMA6D expression are found in breast tumors and coincide with cancer growth, chemoresistance, and recurrence. The gene discussed is SEMA6D; the disease is cancer.